E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/28/2023 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley sells $446,000 11.25% contingent income autocallables on ETFs

Chicago, July 28 – Morgan Stanley Finance LLC priced $446,000 of contingent income autocallable securities due Jan. 24, 2025 linked to the worst performing of the SPDR S&P Biotech ETF and Energy Select Sector SPDR Fund, according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 11.25%, paid monthly, if each underlying fund closes at or above its 60% downside threshold on the related monthly observation date.

The securities will be called automatically starting Jan. 22, 2024 at par if the price of each underlying fund is greater than or equal to its initial price on any monthly call determination date.

At maturity the payout will be par unless the worst performing ETF closes below its 60% downside threshold level in which case investors will be fully exposed to the decline of the worst performing ETF.

The notes are guaranteed by Morgan Stanley.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Contingent income autocallable securities
Underlying ETFs:SPDR S&P Biotech ETF and Energy Select Sector SPDR Fund
Amount:$446,000
Maturity:Jan. 24, 2025
Coupon:11.25% annual rate, paid monthly, if each underlying fund closes at or above its 60% downside threshold on the related monthly observation date
Price:Par
Payout at maturity:Par unless the worst performing ETF closes below its downside threshold level in which case investors will be fully exposed to the decline in the worst performing ETF
Call:Automatically starting Jan. 22, 2024 at par if the price of each underlying fund is greater than or equal to its initial price on any monthly call determination date
Initial levels:$84.97 for Biotech ETF, $84.30 for Energy Fund
Downside thresholds:$50.982 for Biotech ETF, $50.58 for Energy Fund, 60% of initial levels
Pricing date:July 21
Settlement date:July 26
Agent:Morgan Stanley & Co. LLC
Fees:0.375%
Cusip:61775HLX3

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.